• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality.

作者信息

Fattizzo Bruno, Giannotta Juri Alessandro, Sciumè Mariarita, Cattaneo Daniele, Bucelli Cristina, Fracchiolla Nicola Stefano, Onida Francesco, Baldini Luca, Barcellini Wilma, Iurlo Alessandra

机构信息

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

University of Milan, Milan, Italy.

出版信息

Leukemia. 2020 Jul;34(7):1957-1960. doi: 10.1038/s41375-020-0877-y. Epub 2020 May 26.

DOI:10.1038/s41375-020-0877-y
PMID:32457356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7250492/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc3/7250492/faed912b41d7/41375_2020_877_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc3/7250492/faed912b41d7/41375_2020_877_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc3/7250492/faed912b41d7/41375_2020_877_Fig1_HTML.jpg

相似文献

1
Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality.对“血液系统恶性肿瘤患者中的 COVID-19”的回复：聚焦于髓系肿瘤及死亡风险因素
Leukemia. 2020 Jul;34(7):1957-1960. doi: 10.1038/s41375-020-0877-y. Epub 2020 May 26.
2
Response to "COVID-19 in persons with haematological cancers".对“血液系统癌症患者中的COVID-19”的回应
Leukemia. 2020 Aug;34(8):2265-2270. doi: 10.1038/s41375-020-0914-x. Epub 2020 Jun 11.
3
COVID-19 and haematological malignancy: navigating a narrow strait.新型冠状病毒肺炎与血液系统恶性肿瘤：穿越狭窄海峡
Lancet Haematol. 2020 Oct;7(10):e701-e703. doi: 10.1016/S2352-3026(20)30252-0. Epub 2020 Aug 13.
4
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
5
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.感染新型冠状病毒肺炎的血液病患者的临床特征与转归：意大利、西班牙和荷兰四家医院的一项回顾性病例研究
Leukemia. 2020 Sep;34(9):2536-2538. doi: 10.1038/s41375-020-0960-4. Epub 2020 Jul 8.
6
Balancing risk and benefit during coronavirus.在新冠疫情期间权衡风险与收益。
Blood. 2020 May 21;135(21):1817. doi: 10.1182/blood.2020006279.
7
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.新型冠状病毒2型感染焦虑和一般人群限制措施延误了急性血液系统恶性肿瘤的诊断和治疗。
Br J Haematol. 2020 Jul;190(1):e5-e8. doi: 10.1111/bjh.16785. Epub 2020 May 25.
8
Multiple myeloma and COVID-19.多发性骨髓瘤与新型冠状病毒肺炎
Leukemia. 2020 Jul;34(7):1961-1963. doi: 10.1038/s41375-020-0879-9. Epub 2020 Jun 1.
9
Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.血液系统恶性肿瘤与 COVID-19 重症风险：对现有证据的探索和批判性评估。
Br J Haematol. 2020 Aug;190(3):336-345. doi: 10.1111/bjh.16956. Epub 2020 Jul 16.
10
Hematologic parameters in patients with COVID-19 infection: a reply.新型冠状病毒肺炎感染患者的血液学参数：答复
Am J Hematol. 2020 Aug;95(8):E215. doi: 10.1002/ajh.25847. Epub 2020 May 29.

引用本文的文献

1
Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的毛细胞白血病患者结局的单中心研究。
EJHaem. 2023 Aug 31;4(4):1200-1202. doi: 10.1002/jha2.764. eCollection 2023 Nov.
2
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2.使用BBIBP-CorV、AZD1222或BNT162b2疫苗完成针对SARS-CoV-2的疫苗接种方案后，血液系统疾病中体液免疫和细胞免疫反应的比较。
Front Med (Lausanne). 2023 Jul 17;10:1176168. doi: 10.3389/fmed.2023.1176168. eCollection 2023.
3

本文引用的文献

1
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?COVID-19、细胞因子和免疫抑制：我们能从严重急性呼吸综合征中学到什么？
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22.
Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.
费城阴性经典型骨髓增殖性肿瘤中的原发性动脉高血压和药物性高血压：一项系统评价
Biomedicines. 2023 Jan 28;11(2):388. doi: 10.3390/biomedicines11020388.
4
COVID-19 in Patients with Hematologic Diseases.血液系统疾病患者中的新型冠状病毒肺炎
Biomedicines. 2022 Nov 29;10(12):3069. doi: 10.3390/biomedicines10123069.
5
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.预测 SARS-CoV-2 感染在血液病患者中的临床演变的因素：系统评价和荟萃分析。
Hematol Oncol. 2023 Feb;41(1):16-25. doi: 10.1002/hon.3084. Epub 2022 Oct 20.
6
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.癌症患者感染 SARS-CoV-2 或罹患 COVID-19 的风险：早期证据的系统综述。
J Cancer Policy. 2022 Sep;33:100338. doi: 10.1016/j.jcpo.2022.100338. Epub 2022 Jun 6.
7
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.接受 JAK 抑制剂治疗的 MPN 患者的免疫失调和感染并发症。
Front Immunol. 2021 Nov 19;12:750346. doi: 10.3389/fimmu.2021.750346. eCollection 2021.
8
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience.诊断和治疗对BCR-ABL1阴性骨髓增殖性肿瘤患者新冠病毒疫苗反应的影响。单中心经验。
Blood Cancer J. 2021 Nov 26;11(11):185. doi: 10.1038/s41408-021-00579-0.
9
Clinical considerations for critically ill COVID-19 cancer patients: A systematic review.危重症COVID-19癌症患者的临床考量：一项系统综述。
World J Clin Cases. 2021 Oct 6;9(28):8441-8452. doi: 10.12998/wjcc.v9.i28.8441.
10
Is COVID-19 less severe in CML patients than in those with other haematological cancers?与其他血液系统癌症患者相比，慢性粒细胞白血病（CML）患者感染新型冠状病毒肺炎（COVID-19）后的病情是否没那么严重？
Br J Haematol. 2022 Feb;196(3):471-472. doi: 10.1111/bjh.17927. Epub 2021 Oct 27.